1. Home
  2. JAZZ vs CIB Comparison

JAZZ vs CIB Comparison

Compare JAZZ & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • CIB
  • Stock Information
  • Founded
  • JAZZ 2003
  • CIB 1945
  • Country
  • JAZZ Ireland
  • CIB Colombia
  • Employees
  • JAZZ N/A
  • CIB N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • CIB Commercial Banks
  • Sector
  • JAZZ Health Care
  • CIB Finance
  • Exchange
  • JAZZ Nasdaq
  • CIB Nasdaq
  • Market Cap
  • JAZZ 7.3B
  • CIB 7.6B
  • IPO Year
  • JAZZ 2007
  • CIB 1995
  • Fundamental
  • Price
  • JAZZ $121.18
  • CIB $32.13
  • Analyst Decision
  • JAZZ Buy
  • CIB Strong Sell
  • Analyst Count
  • JAZZ 14
  • CIB 3
  • Target Price
  • JAZZ $173.93
  • CIB $33.67
  • AVG Volume (30 Days)
  • JAZZ 567.6K
  • CIB 215.9K
  • Earning Date
  • JAZZ 02-26-2025
  • CIB 02-18-2025
  • Dividend Yield
  • JAZZ N/A
  • CIB 10.01%
  • EPS Growth
  • JAZZ 458.10
  • CIB N/A
  • EPS
  • JAZZ 7.04
  • CIB 1.51
  • Revenue
  • JAZZ $3,992,712,000.00
  • CIB $5,143,377,225.00
  • Revenue This Year
  • JAZZ $7.51
  • CIB N/A
  • Revenue Next Year
  • JAZZ $6.84
  • CIB $3.23
  • P/E Ratio
  • JAZZ $17.22
  • CIB $5.51
  • Revenue Growth
  • JAZZ 5.23
  • CIB 3.66
  • 52 Week Low
  • JAZZ $99.06
  • CIB $30.25
  • 52 Week High
  • JAZZ $134.17
  • CIB $37.85
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 46.66
  • CIB 47.27
  • Support Level
  • JAZZ $118.72
  • CIB $31.78
  • Resistance Level
  • JAZZ $124.66
  • CIB $33.14
  • Average True Range (ATR)
  • JAZZ 2.82
  • CIB 0.55
  • MACD
  • JAZZ -0.21
  • CIB 0.01
  • Stochastic Oscillator
  • JAZZ 31.62
  • CIB 48.21

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About CIB BanColombia S.A.

BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala.

Share on Social Networks: